Combination of Osimertinib and Bevacizumab as First-line Treatment for Patients With Metastatic EGFR-Mutant Lung Cancers-Reply.
作者信息
Schoenfeld Adam J, Yu Helena A
机构信息
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
出版信息
JAMA Oncol. 2020 Dec 1;6(12):1983. doi: 10.1001/jamaoncol.2020.4824.
PMID:33119042
Abstract
摘要
Zotero 插件